ATLANTA (AP) — Belgian pharmaceutical company UCB announced Tuesday that it would invest $2 billion to build a drug-making plant in suburban Atlanta.
The rapidly growing drugmaker said the plant, which would employ about 330 people upon completion, would anchor its effort to sell more drugs in the United States.
“This decision reflects our confidence in UCB’s long-term growth and our deep-rooted commitment to the United States,” company CEO Jean-Christophe Tellier said in a statement…